Express News | JPMorgan Chase & Co's Long Position in H Shares of WuXi AppTec Increases to 9.08% on Nov 22 From 8.54% - HKEX

ReutersNov 27 04:21 ET

Southwest Securities: CXO industry revenues are recovering season by season, but the demand for preclinical services still needs to be restored.

From a short-term perspective, commercial orders continue to be digested, putting pressure on the apparent performance of CDMO; overseas mature CXO clinical pipelines are steadily advancing, and the preclinical demand still needs to be restored.

Zhitong FinanceNov 26 01:00 ET

Trending Industry Today: WUXI APPTEC Leads Losses In Biotechnology Stocks

Moomoo NewsNov 22 02:50 ET

Trending Industry Today: PHARMARON Leads Losses In CRO Stocks

Moomoo NewsNov 22 02:40 ET

Hong Kong stocks fluctuate | CRO concept continues to decline, domestic biomedical investment and financing still at the bottom, overseas business development uncertainty increases.

CRO concept stocks continue to decline. As of the time of writing, wuxi apptec (02359) is down 6.13%, trading at 45.9 Hong Kong dollars; tigermed (03347) is down 5.88%, trading at 32 Hong Kong dollars; pharmaron (03759) is down 5.71%, trading at 13.2 Hong Kong dollars.

Zhitong FinanceNov 22 01:52 ET

Hong Kong Shares Edge Higher, Supported by Consumer Stocks -- Market Talk

WSJNov 21 20:52 ET